|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 51/43 | (2006.01) |
| C07C 51/43 | (2013.01) | ||
| C07C 59/70 | (2006.01) | ||
| A61K 38/28 | (2013.01) | ||
| A61K 38/28 | (2006.01) | ||
| A61K 31/5575 | (2013.01) | ||
| A61K 31/5575 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 9/08 | (2018.01) | ||
| A61P 9/08 | (2006.01) |
| (11) | Patento numeris | 3853200 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19773695.2 |
| Europos patento paraiškos padavimo data | 2019-09-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-07-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/050632 |
| Data | 2019-09-11 |
| (87) | Numeris | WO 2020/060823 |
| Data | 2020-03-26 |
| (30) | Numeris | Data | Šalis |
| 201862732799 P | 2018-09-18 | US |
| (72) |
REMICK, David Michael , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ERBUMINE SALT OF TREPROSTINIL |
| ERBUMINE SALT OF TREPROSTINIL |